Temporal Trends and Disparities in Liver Cell Carcinoma and Hepatic Failure Mortality in the United States: A 24-Year Analysis from CDC WONDER, 1999-2023
ASIDE Gastroenterology · 27.07.2026 · 2 (4) · 8-15
DOI: 10.71079/aside.gi.072726719 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASIDE Gastroenterology, online erschienen am 27.07.2026. Verfasst von Sardar Muhammad Imran Khan und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Liver cell carcinoma (LCC) and hepatic failure (HF) are significant contributors to liver-related mortality in the United States. This study assessed LCC- and HF-related mortality trends (1999–2023) using CDC WONDER data, stratified by demographics and geography.
Methods
Deaths among U.S. adults aged ≥25 years with LCC (ICD-10: C22.0) or HF (ICD-10: K72.9) as underlying or contributing causes were analyzed. AAMRs per 1,000,000 were calculated by direct standardization to the 2000 U.S. standard population. Joinpoint regression estimated annual percent changes (APCs) in AAMRs, stratified by sex (1999–2023) and race/ethnicity, urban-rural status, census region, and state (1999–2020).
Results
From 1999–2023, 22,963 adult deaths were recorded (77.6% men). Overall AAMR declined from 1999–2007 (APC: −2.4), was stable through 2017 (APC: +0.2), then fell through 2023 (APC: −3.5). Male AAMR followed a non-linear trajectory (APC: −2.1, 1999–2010; +0.7, 2010–2017; −4.4, 2017–2023); female AAMR was stable post-2006 (APC: −0.1). NH Asian or Pacific Islanders showed the steepest decline (APC: −6.7); Hispanics increased post-2010 (APC: +0.6). Metropolitan AAMR declined overall; non-metropolitan AAMR increased (APC: +1.3). The West had the highest regional AAMR (5.6 per 1,000,000); Hawaii the highest state-level AAMR (10.3 per 1,000,000).
Conclusion
LCC- and HF-related mortality declined overall, with descriptive subgroup variation by sex, race/ethnicity, urbanization, and geography. Targeted screening, hepatitis management, and equitable healthcare access are needed to address these patterns.
Zitieren
APA
Khan, S. M. I., Khawar, M., Khan, M. H., Jajja, S. A., Fatima, A., Malik, M. A., Khawar, M. M. H., & Qadeer, A. (2026). Temporal Trends and Disparities in Liver Cell Carcinoma and Hepatic Failure Mortality in the United States: A 24-Year Analysis from CDC WONDER, 1999-2023. ASIDE Gastroenterology, 2(4), 8-15. https://doi.org/10.71079/aside.gi.072726719
Vancouver
Khan SMI, Khawar M, Khan MH, Jajja SA, Fatima A, Malik MA, et al. Temporal Trends and Disparities in Liver Cell Carcinoma and Hepatic Failure Mortality in the United States: A 24-Year Analysis from CDC WONDER, 1999-2023. ASIDE Gastroenterology. 2026;2(4):8-15. doi:10.71079/aside.gi.072726719
BibTeX
@article{Khan2026,
author = {Khan, Sardar Muhammad Imran and Khawar, Muneeb and Khan, Muhammad Haris and Jajja, Salman Ayub and Fatima, Ayesha and Malik, Mohammad Azeem and Khawar, Mirza Muhammad Hadeed and Qadeer, Abdul},
title = {Temporal Trends and Disparities in Liver Cell Carcinoma and Hepatic Failure Mortality in the United States: A 24-Year Analysis from CDC WONDER, 1999-2023},
journal = {ASIDE Gastroenterology},
year = {2026},
volume = {2},
number = {4},
pages = {8--15},
doi = {10.71079/aside.gi.072726719}
}
EUVIMED